Feature|Articles|August 20, 2025
- Pharmaceutical Executive: August 2025
- Volume 45
- Issue 6
2025 Emerging Pharma Leaders
Author(s)Mike Hollan
Listen
0:00 / 0:00
Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives steering innovative scientific and strategic pursuits in R&D, market access, and patient support.
Advertisement
Follow the links below to read about each selection:
(In alphabetical order)
*These five individuals were chosen from a pool of nominations by the Pharmaceutical Executive Editorial staff. Selections were based on a number of criteria and review of professional accomplishments and progression of responsibilities in line with those executives inhabiting key “c-suite” functions.
Articles in this issue
about 1 year ago
The CAR-T Climbabout 1 year ago
An RNA-Guided Pathabout 1 year ago
Acceleration and Ambitionabout 1 year ago
Driving Disruption in Deliveryabout 1 year ago
Building Promise from Precisionabout 1 year ago
Determined Problem-Solverabout 1 year ago
Direct-to-Consumer Prescription Care Comes of Ageabout 1 year ago
How to Get Product Iteration Right in HealthcareAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5